格列卫-话题@MedSci

#格列卫#

20篇内容 | 940人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1361670, encodeId=d95213616e07d, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=Cancer Res：王跃祥研究组发现克服胃肠间质瘤格列卫耐药新策略, objectType=article, longId=208725, objectId=3f90208e2506, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f90208e2506, replyNumber=0, likeNumber=35, createdTime=2021-03-21, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f90208e2506, moduleTitle=Cancer Res：王跃祥研究组发现克服胃肠间质瘤格列卫耐药新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f90208e2506)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361669, encodeId=141f13616692b, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=三代“格列卫”同台竞技尼洛替尼又一适应症获批, objectType=article, longId=183424, objectId=2fdc183424d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fdc183424d8, replyNumber=0, likeNumber=45, createdTime=2019-11-24, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fdc183424d8, moduleTitle=三代“格列卫”同台竞技尼洛替尼又一适应症获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fdc183424d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361668, encodeId=3f6813616687b, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=修美乐、格列卫等再降价, objectType=article, longId=178991, objectId=b4d71e899192, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4d71e899192, replyNumber=0, likeNumber=44, createdTime=2019-09-07, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4d71e899192, moduleTitle=修美乐、格列卫等再降价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4d71e899192)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361667, encodeId=2062136166e82, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=格列卫：十余年的构效关系研究, objectType=article, longId=165701, objectId=3246165e016a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3246165e016a, replyNumber=0, likeNumber=43, createdTime=2019-05-10, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3246165e016a, moduleTitle=格列卫：十余年的构效关系研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3246165e016a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361666, encodeId=20f313616668b, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=格列卫再降价, objectType=article, longId=163085, objectId=7f20163085db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f20163085db, replyNumber=0, likeNumber=41, createdTime=2019-03-29, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f20163085db, moduleTitle=格列卫再降价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f20163085db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361665, encodeId=e51413616652d, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=4+7未中选药品大降价！格列卫历史很低, objectType=article, longId=161752, objectId=aef1161e524f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aef1161e524f, replyNumber=0, likeNumber=37, createdTime=2019-03-08, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aef1161e524f, moduleTitle=4+7未中选药品大降价！格列卫历史很低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aef1161e524f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361664, encodeId=00171361664cc, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=带量采购后国产「格列卫」卖出全球很低价, objectType=article, longId=155859, objectId=3621155859a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3621155859a0, replyNumber=0, likeNumber=44, createdTime=2018-12-16, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3621155859a0, moduleTitle=带量采购后国产「格列卫」卖出全球很低价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3621155859a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361663, encodeId=db01136166396, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=11城试点药品集中采购，易瑞沙、格列卫等抗癌药或大幅降价, objectType=article, longId=155498, objectId=d2181554987d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2181554987d, replyNumber=0, likeNumber=39, createdTime=2018-12-11, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2181554987d, moduleTitle=11城试点药品集中采购，易瑞沙、格列卫等抗癌药或大幅降价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2181554987d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361662, encodeId=7862136166203, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=亚盛医药抗格列卫耐药新药HQP1351临床进展入选2018年美国血液学会年会口头报告, objectType=article, longId=154066, objectId=d89f154066ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d89f154066ed, replyNumber=0, likeNumber=0, createdTime=2018-11-23, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d89f154066ed, moduleTitle=亚盛医药抗格列卫耐药新药HQP1351临床进展入选2018年美国血液学会年会口头报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d89f154066ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361661, encodeId=2c211361661ef, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=格列卫后，又一知名药大降价！, objectType=article, longId=144211, objectId=234714421150, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=234714421150, replyNumber=0, likeNumber=33, createdTime=2018-07-14, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=234714421150, moduleTitle=格列卫后，又一知名药大降价！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=234714421150)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361660, encodeId=9b9b136166041, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=格列卫降价了！, objectType=article, longId=142936, objectId=7565142936ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7565142936ec, replyNumber=0, likeNumber=39, createdTime=2018-07-12, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7565142936ec, moduleTitle=格列卫降价了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7565142936ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361659, encodeId=c2df1361659a0, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=格列卫纳入国家医保目录惠及更多患者, objectType=article, longId=113757, objectId=36d2113e5721, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36d2113e5721, replyNumber=0, likeNumber=31, createdTime=2017-09-24, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36d2113e5721, moduleTitle=格列卫纳入国家医保目录惠及更多患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36d2113e5721)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361658, encodeId=c403136165840, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=NEJM: 格列卫（Imatinib）对于慢性粒细胞白血病（CML）十年长期疗效及副作用的报导, objectType=article, longId=91400, objectId=d87e9140061, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d87e9140061, replyNumber=0, likeNumber=41, createdTime=2017-03-12, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d87e9140061, moduleTitle=NEJM: 格列卫（Imatinib）对于慢性粒细胞白血病（CML）十年长期疗效及副作用的报导, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d87e9140061)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361657, encodeId=126b136165ed1, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=Diabetes：抗癌药物格列卫可治疗2型糖尿病, objectType=article, longId=65708, objectId=4ebd65e084e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ebd65e084e, replyNumber=0, likeNumber=40, createdTime=2016-03-31, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ebd65e084e, moduleTitle=Diabetes：抗癌药物格列卫可治疗2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ebd65e084e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361656, encodeId=0e6b13616561f, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=抗癌药物格列卫专利到期患者使用伊马替尼5年可省10万美元, objectType=article, longId=65158, objectId=810765158aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=810765158aa, replyNumber=0, likeNumber=51, createdTime=2016-03-23, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=810765158aa, moduleTitle=抗癌药物格列卫专利到期患者使用伊马替尼5年可省10万美元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=810765158aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361655, encodeId=8fb013616559a, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=Clinical Cancer Research：格列卫（Gleevec）药物是否对脑癌有效？, objectType=article, longId=47017, objectId=00d34e01722, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00d34e01722, replyNumber=0, likeNumber=40, createdTime=2015-02-13, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00d34e01722, moduleTitle=Clinical Cancer Research：格列卫（Gleevec）药物是否对脑癌有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00d34e01722)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361654, encodeId=ddaf136165455, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=进口抗癌药格列卫成天价特殊环境催高药价, objectType=article, longId=45406, objectId=a19b4540688, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a19b4540688, replyNumber=0, likeNumber=33, createdTime=2015-01-15, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a19b4540688, moduleTitle=进口抗癌药格列卫成天价特殊环境催高药价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a19b4540688)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361653, encodeId=a7841361653ab, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=格列卫仿制药的未来之路, objectType=article, longId=21809, objectId=bb922180965, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb922180965, replyNumber=0, likeNumber=39, createdTime=2013-07-21, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb922180965, moduleTitle=格列卫仿制药的未来之路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb922180965)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361652, encodeId=4a7c1361652fd, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=淀粉胶囊假药-“格列卫”, objectType=article, longId=18820, objectId=0aaf1882015, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0aaf1882015, replyNumber=0, likeNumber=45, createdTime=2013-05-18, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0aaf1882015, moduleTitle=淀粉胶囊假药-“格列卫”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0aaf1882015)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361651, encodeId=44d01361651d6, content=<a href='/topic/show?id=da2c6229184' target=_blank style='color:#2F92EE;'>#格列卫#</a>, objectTitle=FDA批准诺格列卫用于Ph阳性儿童急性淋巴细胞白血病, objectType=article, longId=14950, objectId=14f61495064, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14f61495064, replyNumber=0, likeNumber=38, createdTime=2013-02-01, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14f61495064, moduleTitle=FDA批准诺格列卫用于Ph阳性儿童急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14f61495064)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

格列卫

2020-05-29

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

Cancer Res：王跃祥研究组发现克服胃肠间质瘤格列卫耐药新策略

2021-03-21

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

三代“格列卫”同台竞技尼洛替尼又一适应症获批

2019-11-24

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

修美乐、格列卫等再降价

2019-09-07

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

格列卫：十余年的构效关系研究

2019-05-10

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

格列卫再降价

2019-03-29

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

4+7未中选药品大降价！格列卫历史很低

2019-03-08

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

带量采购后国产「格列卫」卖出全球很低价

2018-12-16

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

11城试点药品集中采购，易瑞沙、格列卫等抗癌药或大幅降价

2018-12-11

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

亚盛医药抗格列卫耐药新药HQP1351临床进展入选2018年美国血液学会年会口头报告

2018-11-23

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

格列卫后，又一知名药大降价！

2018-07-14

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

格列卫降价了！

2018-07-12

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

格列卫纳入国家医保目录惠及更多患者

2017-09-24

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

NEJM: 格列卫（Imatinib）对于慢性粒细胞白血病（CML）十年长期疗效及副作用的报导

2017-03-12

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

Diabetes：抗癌药物格列卫可治疗2型糖尿病

2016-03-31

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

抗癌药物格列卫专利到期患者使用伊马替尼5年可省10万美元

2016-03-23

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

Clinical Cancer Research：格列卫（Gleevec）药物是否对脑癌有效？

2015-02-13

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

进口抗癌药格列卫成天价特殊环境催高药价

2015-01-15

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

格列卫仿制药的未来之路

2013-07-21

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

淀粉胶囊假药-“格列卫”

2013-05-18

luoxiaog (审核中...)

前往app查看评论内容

#格列卫#

FDA批准诺格列卫用于Ph阳性儿童急性淋巴细胞白血病

2013-02-01

科室
- - 订阅+
  - 更多科室
工具
服务